Media Coverage · April 13, 2017
“Top 100 startups to invest in” – Challenges Magazine
April 2017. Weekly business magazine Challenges features Acticor Biotech in its special report on the “Top 100 startups to invest in”.
Download full text article (PDF, French)Read next in 'Media Coverage'
- Novel antiplatelet could circumvent bleeding risk for stroke patients
- Experimental antiplatelet compound for acute stroke shows promise
- New drug to prevent clots clears safety hurdle
- New blood thinner may prevent stroke, without risk for bleeding
- Acticor's blood thinner cuts hemorrhage risk in human study, could offer hope for acute stroke